top of page

Publications

Filter by:

Plasma Cell-free RNA Sequencing Enables Sensitive Detection of Lung Cancer

Publications

10 Sept 2023

Plasma Cell-free RNA Sequencing Enables Sensitive Detection of Lung Cancer

Read More
Plasma Cell-free RNA Sequencing Enables Sensitive Detection of Lung Cancer
Assessing the utility of liquid biopsy for determining actionable genetic mutations among indigenous Ghanaian women with metastatic Breast Cancer

Publications

31 May 2023

Assessing the utility of liquid biopsy for determining actionable genetic mutations among indigenous Ghanaian women with metastatic Breast Cancer

Read More
Assessing the utility of liquid biopsy for determining actionable genetic mutations among indigenous Ghanaian women with metastatic Breast Cancer
Liquid biopsy in combination with PET/CT versus PET/CT alone in diagnosis of lung cancer in small nodules.

Publications

31 May 2023

Liquid biopsy in combination with PET/CT versus PET/CT alone in diagnosis of lung cancer in small nodules.

Read More
Liquid biopsy in combination with PET/CT versus PET/CT alone in diagnosis of lung cancer in small nodules.
Longitudinal tracking of ALK-positive lung cancer from plasma using circulating-tumor RNA and circulating-tumor DNA in the BRIGHTSTAR clinical trial

Publications

31 May 2023

Longitudinal tracking of ALK-positive lung cancer from plasma using circulating-tumor RNA and circulating-tumor DNA in the BRIGHTSTAR clinical trial

Read More
Longitudinal tracking of ALK-positive lung cancer from plasma using circulating-tumor RNA and circulating-tumor DNA in the BRIGHTSTAR clinical trial
Development and evaluation of a multi-cancer screening (MCS) test for cancers common in Asia.

Publications

31 May 2023

Development and evaluation of a multi-cancer screening (MCS) test for cancers common in Asia.

Read More
Development and evaluation of a multi-cancer screening (MCS) test for cancers common in Asia.
Combining plasma and tissue next-generation sequencing provides optimal treatment selection for metastatic NSCLC: a comparative study.

Publications

31 May 2023

Combining plasma and tissue next-generation sequencing provides optimal treatment selection for metastatic NSCLC: a comparative study.

Read More
Combining plasma and tissue next-generation sequencing provides optimal treatment selection for metastatic NSCLC: a comparative study.
Complete mutation concordance with amplicon-based NGS between peripheral blood and bone marrow at 0.5% VAF threshold

Publications

1 May 2023

Complete mutation concordance with amplicon-based NGS between peripheral blood and bone marrow at 0.5% VAF threshold

Read More
Complete mutation concordance with amplicon-based NGS between peripheral blood and bone marrow at 0.5% VAF threshold
Clinical Validation of a Promising New Amplicon-Based Liquid Biopsy Platform for Detection of Guideline Recommended Biomarkers in Metastatic NSCLC

Publications

1 Mar 2023

Clinical Validation of a Promising New Amplicon-Based Liquid Biopsy Platform for Detection of Guideline Recommended Biomarkers in Metastatic NSCLC

Read More
Clinical Validation of a Promising New Amplicon-Based Liquid Biopsy Platform for Detection of Guideline Recommended Biomarkers in Metastatic NSCLC
Liquid biopsy NGS test identifies actionable DNA mutations from CSF specimens of lung cancer patients

Publications

1 Nov 2022

Liquid biopsy NGS test identifies actionable DNA mutations from CSF specimens of lung cancer patients

Read More
Liquid biopsy NGS test identifies actionable DNA mutations from CSF specimens of lung cancer patients

1

/

8

bottom of page